Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Obesity Study

From Blood Monocytes to Adipose Tissue-Resident Macrophages

Induction of Diapedesis by Human Mature Adipocytes

  1. Cyrile A. Curat1,
  2. Alexandra Miranville1,
  3. Coralie Sengenès1,
  4. Michael Diehl2,
  5. Carolin Tonus3,
  6. Rudi Busse1 and
  7. Anne Bouloumié14
  1. 1Department of Cardiovascular Physiology, J.W. Goethe University, Frankfurt am Main, Germany
  2. 2Department of Internal Medicine II, Klinikum Offenbach, Offenbach, Germany
  3. 3Department of Surgery I, Klinikum Offenbach, Offenbach, Germany
  4. 4Obesity Research Unit, INSERM U 586, Université Paul Sabatier, Toulouse, France
  1. Address correspondence and reprint requests to Cyrile A. Curat, Institut für Kardiovaskuläre Physiologie, J.W. Goethe-Universität, Theodor-Stern-Kai 7, D-60 596 Frankfurt/Main, Germany. E-mail: curat{at}zphys1.uni-frankfurt.de
Diabetes 2004 May; 53(5): 1285-1292. https://doi.org/10.2337/diabetes.53.5.1285
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Induction of Diapedesis by Human Mature Adipocytes

Abstract

Obesity has been suggested to be a low-grade systemic inflammatory state, therefore we studied the interaction between human adipocytes and monocytes via adipose tissue (AT)-derived capillary endothelium. Cells composing the stroma-vascular fraction (SVF) of human ATs were characterized by fluorescence-activated cell sorter (FACS) analysis and two cell subsets (resident macrophages and endothelial cells [ECs]) were isolated using antibody-coupled microbeads. Media conditioned by mature adipocytes maintained in fibrin gels were applied to AT-derived ECs. Thereafter, the expression of endothelial adhesion molecules was analyzed as well as the adhesion and transmigration of human monocytes. FACS analysis showed that 11% of the SVF is composed of CD14+/CD31+ cells, characterized as resident macrophages. A positive correlation was found between the BMI and the percentage of resident macrophages, suggesting that fat tissue growth is associated with a recruitment of blood monocytes. Incubation of AT-derived ECs with adipocyte-conditioned medium resulted in the upregulation of EC adhesion molecules and the increased chemotaxis of blood monocytes, an effect mimicked by recombinant human leptin. These results indicate that adipokines, such as leptin, activate ECs, leading to an enhanced diapedesis of blood monocytes, and suggesting that fat mass growth might be linked to inflammatory processes.

  • AT, adipose tissue
  • EC, endothelial cell
  • FACS, fluorescence-activated cell sorter
  • FITC, fluorescein isothiocyanate
  • GM-CSF, granulocyte macrophage-colony stimulating factor
  • ICAM, intracellular adhesion molecule
  • IFN, interferon
  • LPS, lipopolysaccharide
  • MCP, monocyte chemoattractant protein
  • MIP, macrophage inflammatory protein
  • PECAM, platelet/EC adhesion molecule
  • PerCP, peridinin chlorophyll-α protein
  • SVF, stroma-vascular fraction

The concept that adipose tissue (AT) is a simple fat storage facility has evolved over the last few years, and current thinking leans toward its recharacterization as a multifunctional secretory organ (1). Indeed, mature adipocytes are involved in endocrine, paracrine, and autocrine regulatory processes (2), through the secretion of a large number of multifunctional molecules now termed adipocytokines or adipokines (3). In addition to playing key roles in the regulation of the lipid and glucose homeostasis, adipokines modify physiological processes, such as hematopoiesis, reproduction, and feeding behavior, and may mediate the genesis of the multiple pathologies associated with an increased fat mass (4,5). Inflammatory processes contribute to the endothelial dysfunction and vascular remodeling that are associated with hypertension and atherosclerosis (6,7), disorders that are clearly linked to obesity. Moreover, in humans, the development of AT has been associated with an increased production of inflammatory markers, including adhesion molecules (P-selectin, intercellular adhesion molecule-1, and plasma E-selectin) and inflammatory cytokines (tumor necrosis factor-α, interleukin-6, interleukin-8, and the monocyte chemoattractant protein 1) (8,9). It is therefore tempting to speculate that adipocytes, via the production of adipokines, are directly involved in the genesis of systemic and vascular inflammation. In the present study, we report the presence of resident macrophages in the stroma-vascular fraction (SVF) of human AT, the number of which is positively correlated with the BMI of AT donors. Furthermore, mature human adipocytes release soluble factors that increase the diapedesis of human blood monocytes across a layer of AT-derived capillary endothelial cells (ECs), an effect that can be mimicked by human recombinant leptin.

RESEARCH DESIGN AND METHODS

RPMI-1640 medium was purchased from Gibco (Invitrogen, Carlsbad, CA) and the EC growth medium and EC basic medium from Promocell (Heidelberg, Germany). The Easysep CD34- and CD14-coupled magnetic beads were from StemCell Technologies (Meylan, France), and the CD31-coupled magnetic Dynabeads were from Dynal (Hamburg, Germany). The human α-thrombin was provided by Hemochrom Diagnostica (Essen, Germany). Ficoll gradient (Biocoll) and collagenase were from Biochrom (Berlin, Germany), and recombinant human leptin and interferon (IFN)-γ were from PeproTech (Cell Concept, Umkirch, Germany). The vibrant phagocytosis system was from Molecular Probes (Leiden, the Netherlands). The mouse monoclonal intracellular adhesion molecule (ICAM)-1 antibody and the goat polyclonal platelet/EC adhesion molecule (PECAM)-1 antibodies used for the Western blot analysis were from Santa Cruz Biotechnology (Santa Cruz, CA). The peroxidase-coupled secondary mouse and goat antibodies were from Calbiochem (Darmstadt, Germany). The mouse monoclonal antibodies directed against von Willebrand factor and CD45 were from Dako (Glostrup, Denmark) and Cymbius biotechnology (Hofheim, Germany), respectively. The anti-rabbit or anti-mouse antibodies conjugated with Alexa Fluor 488 were from Molecular Probes. The labeled mouse IgG coupled with phycoerythrin (PE), fluorescein isothiocyanate (FITC), peridinin chlorophyll-α protein (PerCP), and the labeled mouse monoclonal antibodies against CD14 and CD45 were from BD Biosciences (Bedford, MA), and the labeled mouse monoclonal antibody against CD31 was from Cymbius biotechnology (Hofheim, Germany). VectaShield mounting medium was provided by Vector Laboratories (Burlingame, CA). All other products were from Sigma (Munich, Germany).

Isolation of the SVF of human AT.

Human subcutaneous AT was obtained from patients undergoing plastic surgery by lipoaspiration of the gluteal regions or lipectomy of the abdominal region (mean BMI 25 ± 1 and 25.3 ± 0.5 kg/m2, respectively). Human visceral AT was obtained from patients undergoing abdominal tumor surgery (colorectal carcinoma, pancreas, and stomach) that was not associated with obvious inflammatory disease (mean BMI 26.3 ± 0.8 kg/m2). The study was approved by the ethics committee of the University Hospital of Frankfurt am Main. After digestion of the AT in a collagenase solution (300 units/ml in PBS and 2% BSA), followed by a 200g centrifugation, the pellet containing the SVF was incubated for 10 min in an erythrocyte-lysing buffer (155 mmol/l NH4Cl, 5.7 mmol/l K2HPO4, and 0.1 mmol/l EDTA) and finally resuspended in PBS/2% FCS and sequentially filtered through 100-, 70-, and 40-μm sieves. The isolation of the human preadipocytes was performed as described (10).

Human mature adipocyte isolation and preparation of the adipocyte-derived secretions.

Adipocytes were isolated as described (11). Briefly, after digestion of the AT in the collagenase solution for 20 min, the resulting suspension was filtered (210-μm polyamid filter) and washed with PBS. Mature adipocytes (∼400,000) were included in fibrin gels (1.5 mg fibrinogen/ml EC basic medium supplemented with 25 units/ml α-thrombin) and cultured in RPMI medium containing 100 units/ml penicillin, 100 μg/ml streptomycin, 4 mmol/l l-glutamin, 1 mmol/l sodium pyruvate, 1% modified Eagle’s medium vitamins, and 1% modified Eagle’s medium nonessential amino acids (RPMI-S). Control gels were prepared without adipocytes. After 24 h, the adipocyte-conditioned media were collected and frozen at −80°C.

Isolation of the ECs and macrophages from the SVF.

The SVF, homogenized at the maximal concentration of 40 million cells per ml of PBS/2% FCS, was incubated at room temperature for 15 min with 100 μl of Easysep positive-selection cocktail per milliliter of cell suspension, followed by a 10-min incubation period with 50 μl of Easysep magnetic nanoparticles per milliliter of cell suspension. After successive magnetic sorting steps and washes with PBS/2%FCS, the CD34+ cell fraction was finally suspended in 1 ml PBS/0.1% BSA, whereas the CD34− subset, collected after each sorting step, was centrifuged at 200g and homogenized in 1 ml PBS/2%FCS.

The CD34+ cell fraction was used to isolate the capillary ECs with 50 μl of CD31-coupled magnetic microbeads (Dynal Biotech, Hamburg, Germany) per milliliter of CD34+ cell fraction. After 20 min of incubation at 4°C under constant shaking, the cell suspension containing the beads was briefly homogenized in 10 ml PBS/0.1%BSA and placed in front of the magnet for 1 min. After two washes in PBS/0.1% BSA, the magnetic bead-coupled fraction, which corresponds to the CD34+/CD31+ cell population, was collected, centrifuged for 10 min at 200g, and cultured on fibronectin-coated dishes in EC growth medium.

The CD34− cell fraction was used to isolate the resident macrophages with 50 μl of CD14-coupled magnetic microbeads (Dynal Biotech) per milliliter of CD34− cell fraction. After 20 min of incubation at 4°C under constant shaking, the cell suspension containing the beads was briefly homogenized in 10 ml PBS/2%FCS and placed in front of the magnet for 1 min. After two washes in PBS/0.1% BSA, the magnetic bead-coupled fraction, which corresponds to the CD34−/CD14+ cell population, was collected and centrifuged for 10 min at 200g.

Fluorescence-activated cell sorter analysis.

Cell sorter (FACS) analyses were performed using the freshly harvested SVF as well as the SVF-derived CD14+/CD34− cell population. Cells were suspended in 100 μl PBS containing 0.5% BSA and 2 mmol/l EDTA and incubated (30 min at 4°C) with labeled monoclonal antibodies (0.5 mg/100 ml CD14-PE, 0.25 mg/100 ml CD45-PerCP, or 1.0 mg/100 ml CD31-FITC) or the appropriate isotype control. After extensive washing with PBS, the labeled cells were analyzed by flow cytometry using a FACSCalibur flow cytometer and CellQuest Pro software (Becton Dickinson, Erembodegem-Aalst, Belgium).

Phagocytosis assay.

Freshly isolated CD14+/CD34− cells were cultured in RPMI supplemented with 10% FCS for 4 h and thereafter treated or not with bacterial lipopolysaccharide (LPS) (serotype 0111:B4, 5 μg/ml) and IFN-γ (240 units/ml) overnight. After media removal, 200 μl of sonicated FITC-labeled Escherichia coli bioparticule mix (Molecular Probes) was added to the cells and incubated for 2 h at 37°C. After three washes with PBS, the cells were fixed with 4% paraformaldehyde and the presence of green fluorescent E. coli particles in the cell cytoplasma, an index of phagocytotic activity, was assessed by fluorescence microscopy.

Immunohistochemistry.

Immunohistochemical analyses were performed using cultured CD14+/CD34− and CD31+/CD34+ cells. After fixation, cells were incubated for 1 h at room temperature with a dilution of the relevant primary antibodies and, after washing in PBS containing 0.2% Tween, for 1 h with the corresponding fluorescence-labeled second antibodies.

Transmigration assays.

Human blood monocytes were isolated from buffy coats obtained from healthy donors (Transfusion Center of Frankfurt Hospital) using a Biocoll gradient solution (density 1.077) (12) and labeled for 40 min with 10 μmol/l calcein acetoxymethyl ester (13). Confluent capillary ECs were incubated overnight with conditioned medium from either mature adipocytes or from preadipocytes, with recombinant human leptin or with control medium. Following incubation, labeled monocytes (30,000 cells/0.5 ml RPMI-S) were added to the capillary ECs for 1 h. The adhesion of the monocytes was assessed using a fluorescence microscope (14), and the number of adherent monocytes was expressed as the percentage of the endothelial nuclei.

Monocyte transendothelial migration was assessed on 3-μm pore, fibronectin-coated, microchemotaxis chambers (Costar, Cambridge, MA) seeded at the density of 100,000 capillary ECs/cm2. After 5–6 days in culture, the cells were incubated overnight with adipocyte-conditioned media, recombinant human leptin, or control medium before exposure to labeled monocytes (130,000 cells/100 μl RPMI-S, 4 h). Monocyte transmigration was evaluated by counting the number of labeled monocytes attached to the lower surface of the wells (15).

RNA extraction and real-time PCR.

Total RNA was extracted from human mature adipocytes, CD14+ cells, and blood monocytes using a RNeasy kit (Qiagen, Hilden, Germany) and its concentration determined using a Ribogreen fluorometric assay (Molecular Probes). RNA (1 μg) was reverse transcribed using the thermoScript RT system from Life Technologies (Invitrogen, Carlsbad, CA). Reactions were also performed without reverse transcriptase to provide a control for contamination of samples with genomic DNA (Table 1).

The PCR mixtures were prepared with SYBR Green Master Mix (Applied Biosystems, Foster City, CA). For the ribosomal RNA quantification (18S rRNA) and the CD36 probe (Assays-on-Demand; Applied Biosystems), the PCR contained the primers, the fluorogenic probe mix, and the TaqMan Universal PCR Master mix (Applied Biosystems). All amplification reactions were performed in duplicate from 20 ng cDNA using the Mx4000 Multiplex Quantitative PCR System (Stratagene, La Jolla, CA) using the following conditions: 50°C for 2 min and 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. Results were analyzed with Strategene MX4000 software, and all values were normalized to the levels of the ribosomal RNAs.

Western blot analysis.

Capillary ECs, stimulated overnight with either adipocyte-conditioned or control media, were lysed on ice for 20 min in Nonidet lysis buffer (20 mmol/l Tris/Cl, pH 7.5, 150 mmol/l NaCl, 10 mmol/l NaPPi, 20 mmol/l NaF, 1% Nonidet P40, 25 mmol/l β-glycerophosphate, 2 mmol/l orthovanadate, 10 μmol/l ocadeic acid, 4 μl/ml phenylmethylsulfonyl fluoride, and 12 μl/ml of protease inhibitor mix). Proteins (20 μg) were separated by SDS-PAGE under denaturing conditions and transferred to nitrocellulose membranes. Membranes were blocked overnight at 4°C, incubated with primary antibody for 90 min, rinsed, and incubated with peroxidase-coupled secondary antibodies for 60 min. The immunocomplexes were visualized using a chemiluminescence reagent (Amersham, Freiburg, Germany), and the autoradiographs were scanned by an imaging densitometer.

Data analysis.

Values are given as means ± SE of n independent experiments. Statistical analyses were performed using Student’s t test or one-way ANOVA, followed by Bonferroni t test where appropriate. Differences were considered significant where P was <0.05.

RESULTS

Identification and characterization of a population of resident macrophages in human ATs.

Three-color FACS analysis of the freshly harvested SVF from human subcutaneous ATs was performed using antibodies directed against the leukocyte common antigen precursor (CD45), the PECAM-1 (CD31), and the LPS receptor (CD14). FACS analysis of the CD14 versus CD31 labeling (Fig. 1A) revealed two distinct cell subsets: a CD31+ and CD14− cell population (14 ± 1.5% of the total SVF) and a double CD31− and CD14+ cell population (10.5 ± 1.5% of the total SVF). FACS analysis of the CD14 and CD45 labeling (Fig. 1B) clearly identified a CD45+ and CD14− cell population (19 ± 5% of the total SVF) as well as a double CD45− and CD14+ cell population (11.5 ± 2% of the total SVF). The double-positive populations (CD31+/CD14+ and CD45+/CD14+) were found to be triple positive when gated for the third marker (CD45 and CD31, respectively) (Fig. 1C and D).

To further characterize the CD14+/CD31+/CD45+ cell population, three-color FACS analysis was performed on the freshly extracted CD14+ cells. All cells expressed both CD31 and CD45 (Fig. 2A). Moreover, in short-term culture the cells exhibited a typical rotund morphology with unilobular nuclei (Fig. 2B). Real-time PCR analysis using specific primers for the thrombospondin receptor (CD36) showed the presence of the CD36 gene in the transcripts of the CD14+ cells in a level similar to that found in the blood monocytes (ratio of 1.09 ± 0.05, n = 10, using blood monocytes as reference). Treatment with LPS and IFN-γ led to an uptake of FITC-labeled E. coli into the cytoplasma of the cells (Fig. 2C, right panel), whereas no specific labeling could be detected in untreated cells (Fig. 2C, left panel), indicating that the CD14+ cell population exhibits phagocytotic activity. It is important to note that the CD14+/CD31+ cell population could be detected by FACS analysis independent of the anatomical source (i.e., subcutaneous gluteal and abdominal as well as visceral) of the AT (Fig. 3A). Moreover, because a significant positive correlation was found between the percentage of the CD14+/CD31+ cells in the SVF and the BMI, it appears that the extent of AT growth is linked to the number of macrophages resident therein (Fig. 3B).

Effect of adipocyte-conditioned medium on the transmigration of blood monocytes through a capillary EC layer.

To determine whether adipocytes are able to recruit blood monocyte/macrophages into AT, we studied the effects of the adipocyte-derived factors on the adhesion and transmigration of monocytes to/through AT-derived capillary ECs. A 2.5-fold increase in the adhesion of labeled monocytes was observed on the capillary ECs preincubated with the adipocyte-derived factors compared with ECs pretreated with control media (P < 0.01, n = 5) (Fig. 4A). Similarly, the migration of labeled-monocytes through a layer of ECs, cultured on transwell filters, was markedly enhanced when the endothelium was pretreated with adipocyte-conditioned medium (threefold increase compared with control medium, P < 0.001, n = 3) (Fig. 4B). A chemotactic effect was only observed using medium from mature adipocytes. Conditioned medium from undifferentiated preadipocytes had no effect on the monocyte adhesion/transmigration (Fig. 5).

Activation of the AT-derived capillary ECs by adipocyte-conditioned medium.

To assess whether the chemotactic effect of the adipocyte-conditioned medium was associated with an EC activation, we determined the effect of the adipocyte-conditioned media on the endothelial expression of the ICAM-1 and PECAM-1. Higher levels of ICAM-1 and PECAM-1 were expressed in ECs pretreated with conditioned medium from mature adipocytes as assessed by immunocytochemical (Fig. 6A and B) and Western blot analyses (1.9- and 1.2-fold increase for ICAM-1 and PECAM-1, respectively, n = 4, P < 0.05) (Fig. 6C).

Nature of the adipocyte-derived product involved in the enhanced adhesion of blood monocytes.

To determine the nature of the adipocyte-derived factors involved in the enhanced adhesion of the blood monocytes, mature adipocyte-derived medium was either heated to denaturate proteins or treated with ether to selectively deplete the adipocyte secretions from lipid components. Lipid depletion did not affect the chemotactic effect of the adipocyte-conditioned medium (Fig. 7A), whereas protein denaturation reduced it markedly (twofold decrease compared with native medium, n = 4, P < 0.01).

To further characterize the adipocyte-derived proteins potentially involved in the chemotactic effect of the adipocyte-conditioned medium, real-time PCR analysis was performed on mature adipocyte mRNA. Monocyte chemoattractant protein (MCP)-1, interleukin-8, and leptin were expressed in human mature adipocytes (Fig. 7B), whereas no specific signal could be detected for granulocyte macrophage-colony stimulating factor (GM-CSF) or macrophage inflammatory protein (MIP)-1α. Moreover, increasing concentrations of recombinant human leptin (from 10 to 1,000 ng/ml) resulted in an increased adhesion and transmigration of blood monocytes in a concentration-dependent manner (Fig. 7C and D). The maximal effect was observed for 1,000 ng/ml leptin (3.5-fold increase in monocyte adhesion, P < 0.001, n = 4, and 7-fold increase in monocyte transmigration, P < 0.01, n = 4).

DISCUSSION

Obesity is rapidly becoming a major public health concern because it is clearly associated with increased risks of cardiovascular pathologies, diabetes, and cancer. However, the link between an excess of fat and the development of such pathological states remains to be elucidated, as do the mechanisms involved in the expansion and development of the AT. While many studies have focused on the role of the adipocytes and their precursors cells, the preadipocytes, other cell types within AT, especially cells composing the so-called SVF, might play a determinant role in disease progression. Recently, a key role of the microcirculation within AT in the increase of the fat mass has been demonstrated in a genetic model of animal obesity (16) and in severe combined immunodeficient (SCID) mice after implantation of preadipocytes (17). In humans, little data are available regarding the nature of the cell types composing the SVF. On the basis of immunohistochemical analysis, one report described the presence of ECs as well as stromal cells, blood cells, and tissue macrophages in the human mammary and visceral ATs (18). In the present study, the FACS analysis revealed a cell population that expressed the cell surface markers characteristic of the monocyte/macrophage lineage, i.e., CD14 (LPS receptor), CD31 (PECAM-1), and CD45 (leukocyte common antigen). Moreover, the isolation of the CD14+ cells using CD14-coupled magnetic microbeads allowed us to demonstrate that the CD14+ cells expressed the CD36 gene, thus excluding the granulocyte lineage, and exhibited in vitro macrophage phenotype and activity. The population of resident macrophages appears to constitute an important component of the SVF since macrophages could be detected in subcutaneous and in visceral AT samples. Tissue macrophages have been shown to perform diverse functions, such as protecting against microorganisms and exerting cytotoxic activity against tumor cells, in addition to regulating local homeostasis via the production of growth factors and cytokines. Macrophages are also present in human tumors, where they are thought to contribute to the promotion of tumor angiogenesis, and in atherosclerotic plaques, where they are important for intracellular lipid accumulation and foam cell formation as well as the modulation of vascular cell function and growth (19–21). Since the number of resident macrophages present in AT was found to correlate positively with BMI, it is tempting to speculate that macrophages might contribute to the growth of the fat mass in a manner similar to that described in tumors. Notably, such a correlation between the amount of AT resident macrophages and obesity has also been observed in various mouse models of obesity and in human subcutaneous AT, as has been reported by two works (22,23) that appeared during the preparation of the study.

AT resident macrophages could originate from either blood monocytes or from preadipocytes. Indeed, preadipocytes have been reported (24,25) to differentiate into macrophages, but the reported differentiation of rodent preadipocytes took place in an environment favored by macrophages. It therefore seems more likely that the macrophage population found in AT originates as a consequence of the recruitment of blood monocytes. Tissue infiltration of blood monocytes is a complex phenomenon that involves several steps, including the activation of the capillary endothelium and the increased expression of adhesion molecules, such as ICAM-1, and the adhesion of blood monocytes, followed by their transmigration across the endothelium and differentiation into macrophages. Ourresults indicate that mature human adipocytes, via the production of soluble factors, stimulated the diapedesis of blood monocytes. The latter response was related to the activation of the AT-derived capillary ECs and an increase in the expression of ICAM-1 and PECAM-1. It should be mentioned that increased plasma concentrations of soluble cell adhesion molecules (E-selectin, VCAM-1, ICAM-1, and von Willebrand factor) have been reported (26,27) in overweight and obese individuals, suggesting that increased fat mass is associated with an early systemic endothelial activation. Thus, adipocyte-derived factors that are released in the systemic circulation might play an important role in the activation of ECs. Among the cytokines or “adipokines” reported to be produced by adipocytes are inflammatory factors, such as interleukin-8 and tumor necrosis factor-α, and chemotactic factors, such as MCP-1, MIP-1, and GM-CSF. Since preadipocyte-conditioned medium exerted no effect on monocyte adhesion, the candidate mediators of monocyte diapedesis can be restricted to those produced and released by differentiated adipocytes. This means, for example, that tumor necrosis factor-α, which is produced by human preadipocytes but not adipocytes (28), could be ruled out. The data obtained by real-time PCR on RNA extracted from mature adipocytes confirmed the low expression of interleukin-8 and MCP-1 (28,29) and the absence of the MIP-1 and GM-CSF in mature human fat cells (28). Leptin, as expected, was strongly expressed in mature adipocytes, and this adipokine was able to mimic the effects of adipocyte-conditioned medium on monocyte adhesion and transmigration. Since the leptin receptor is known to be expressed in ECs derived from human AT (18) and leptin induces an oxida-tive stress in ECs (30,31), the results of the present study strongly suggest that leptin could elicit EC activation and the infiltration of circulating blood monocytes into AT. However, it has to be noticed that in the models of leptin-deficient and leptin receptor-deficient mice, the amount of resident macrophages still correlates with the degree of obesity, as has been recently reported (22,23), suggesting that adipokines other than leptin may participate in the adipocyte-mediated diapedesis.

In conclusion, adipokines, most likely leptin, derived from mature human adipocytes, activate microvascular ECs, and thus promote monocyte diapedesis and the accumulation of macrophages within AT. It is tempting to speculate that the increase in fat mass that is associated with the enhanced release of adipocyte-derived factors, such as leptin into the circulation, contributes to the development of a systemic inflammatory state and may therefore be involved in the pathogenesis of obesity-associated vascular pathologies.

FIG. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 1.

Flow cytometry analysis of the SVF. Representative triple-color FACS analysis performed on total SVF using CD14(PE) and CD31(FITC) antibodies (A) or CD14(PE) and CD45(PerCP) antibodies (B). Representative FACS analysis of the gated CD45+ population (C) and of the gated CD31+ population (D).

FIG. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 2.

Characterization of the isolated CD14+ cells. A: Representative FACS analysis of CD14+ cells using antibodies against CD14(PE), CD45(PerCP), and CD31(FITC). B: Phase-contrast microscopy (×100 magnification) and immunocytochemical analysis using an antibody against CD45 of the cultured CD14+ cells. C: Phagocytosis assays using FITC-labeled E. coli performed on the CD14+ cells stimulated (right panel) or not (left panel) with 5 μg/ml LPS and 240 units/ml IFN-γ (n = 5).

FIG. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 3.

Influence of the source of AT and BMI. A: Percentage of the CD14+/CD31+ population determined by FACS analysis of SVF of gluteal (n = 19), abdominal (n = 7), and visceral (n = 17) AT samples. B: Correlation between the percentage of CD14+/CD31+ cells in the gluteal SVF and BMI (n = 19, P = 0.0045, r2 = 0.3863).

FIG. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 4.

Effect of adipocyte-derived factors on the diapedesis of blood monocytes. A: Adhesion of calcein-labeled monocytes to AT-derived ECs pretreated or not with adipocyte-conditioned media. Representative fluorescence microscopy analyses are shown, and values are means ± SE of the number of adherent monocytes expressed as the percentage of the endothelial nuclei (n = 5). **P < 0.01 versus control. B: Transmigration of calcein-labeled monocytes through AT-derived ECs pretreated or not with adipocyte-conditioned media. Representative fluorescence microscopy analyses are shown, and values are means ± SE of the number of transmigrated monocytes per surface unit of the lower part of the well (n = 3). ***P < 0.001 versus control.

FIG. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 5.

Specificity of adipocyte-derived factors. The values are mean ± SE of the percentage of adherent monocytes to AT-derived ECs pretreated or not with adipocyte- or preadipocyte-conditioned media, n = 3,** P < 0.01 versus control.

FIG. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 6.

Activation of AT-derived ECs by adipocyte-derived factors. AT-derived ECs were incubated with either adipocyte-conditioned medium or control medium. A and B: Immunocytochemical analyses performed using ICAM-1 and PECAM-1 antibodies, respectively (n = 3). C: Western blot analyses using ICAM-1 and PECAM-1 antibodies (n = 4).

FIG. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 7.

Nature and characterization of the adipocyte-derived factors. A: Adhesion of monocytes to AT-derived ECs pretreated or not with native, heated, or ether-extracted adipocyte-conditioned medium. The number of adherent monocytes was expressed as the percentage of the endothelial nuclei, and the values are means ± SE of the percentage of control (n = 4). **P < 0.01. B: mRNA expression of GM-CSF, MIP-1α, MCP-1, interleukin-8, and leptin in mature adipocytes. Values are means ± SE of the normalized values to 18S (n = 4). C: Adhesion of monocytes to AT-derived ECs pretreated with increasing concentrations of human recombinant leptin. The number of adherent monocytes was expressed as the percentage of the endothelial nuclei, and the values are means ± SE (n = 4). **P < 0.01, ***P < 0.001 versus control. D: Transmigration of monocytes to AT-derived ECs pretreated with increasing concentrations of human recombinant leptin. The number of transmigrated monocytes was counted per surface unit of the lower part of the well, and values are means ± SE (n = 4). **P < 0.01 versus control.

View this table:
  • View inline
  • View popup
TABLE 1

Primer sequences

Acknowledgments

This study was funded by the Sofja Kovalevskaja prize (Alexander von Humbolt foundation and the German Federal Ministry of Education and Research).

We thank Valérie Wegner and Steffi Hauk for excellent technical support. We also thank Dr. Ingrid Fleming for critical reading of the manuscript.

Footnotes

    • Accepted February 18, 2004.
    • Received December 12, 2003.
  • DIABETES

REFERENCES

  1. ↵
    Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW: Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord27 :875 –888,2003
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab11 :327 –332,2000
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol19 :972 –978,1999
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Chaldakov GN, Stankulov IS, Hristova M, Ghenev PI: Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des9 :1023 –1031,2003
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Rajala MW, Scherer PE: Minireview: the adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology144 :3765 –3773,2003
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Das UN: Is obesity an inflammatory condition? Nutrition17 :953 –966,2001
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Lyon CJ, Law RE, Hsueh WA: Minireview: adiposity, inflammation, and atherogenesis. Endocrinology144 :2195 –2200,2003
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM: Leptin regulates proinflammatory immune responses. FASEB J12 :57 –65,1998
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H: Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem278 :46654 –46660,2003
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J: Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia38 :764 –771,1995
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Rodbell M: Localization of lipoprotein lipase in fat cells of rat adipose tissue. J Biol Chem239 :753 –755,1964
    OpenUrlFREE Full Text
  12. ↵
    Maxeiner H, Husemann J, Thomas CA, Loike JD, El Khoury J, Silverstein SC: Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2. J Exp Med188 :2257 –2265,1998
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Braut-Boucher F, Pichon J, Rat P, Adolphe M, Aubery M, Font J: A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes. J Immunol Methods178 :41 –51,1995
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Giri R, Selvaraj S, Miller CA, Hofman F, Yan SD, Stern D, Zlokovic BV, Kalra VK: Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am J Physiol Cell Physiol283 :C895 –C904,2002
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Zhang H, Issekutz AC: Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668. Am J Pathol160 :2219 –2230,2002
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ: Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A99 :10730 –10735,2002
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Chatterjee VK, Garkavtsev I, Jain RK: Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res93 :E88 –E97,2003 [published erratum in Circ Res 94:E16, 2004]
  18. ↵
    Bornstein SR, Abu-Asab M, Glasow A, Path G, Hauner H, Tsokos M, Chrousos GP, Scherbaum WA: Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes49 :532 –538,2000
    OpenUrlAbstract
  19. ↵
    Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res56 :4625 –4629,1996
    OpenUrlAbstract/FREE Full Text
  20. Vacca A, Ribatti D, Ruco L, Giacchetta F, Nico B, Quondamatteo F, Ria R, Iurlaro M, Dammacco F: Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas. Br J Cancer79 :965 –970,1999
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Takahashi K, Takeya M, Sakashita N: Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc35 :179 –203,2002
    OpenUrlCrossRefPubMed
  22. ↵
    Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest112 :1796 –1808,2003
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest112 :1821 –1830,2003
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    Cousin B, Andre M, Casteilla L, Penicaud L: Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol186 :380 –386,2001
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, Casteilla L: Preadipocyte conversion to macrophage: evidence of plasticity. J Biol Chem278 :9850 –9855,2003
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, De Mattia G: Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension34 :568 –573,1999
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Kvasnicka T, Kvasnicka J, Ceska R, Grauova B, Vrablik M: Increasing plasma levels of soluble cell adhesion molecules (sE-Selectin, sP-Selectin and sICAM-1) in overweight adults with combined hyperlipidemia. Sb Lek102 :473 –477,2001
    OpenUrlPubMed
  28. ↵
    Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD: Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol175 :81 –92,2001
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    Bruun JM, Lihn AS, Madan AK, Pedersen SB, Schiott KM, Fain JN, Richelsen B: Higher production of interleukin-8 in visceral compared to subcutaneous adipose tissue: implications of non-adipose cells in adipose tissue. Am J Physiol Endocrinol Metab286 :E8 –E13,2004
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Bouloumie A, Marumo T, Lafontan M, Busse R: Leptin induces oxidative stress in human endothelial cells. FASEB J13 :1231 –1238,1999
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem276 :25096 –25100,2001
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this Issue

May 2004, 53(5)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
From Blood Monocytes to Adipose Tissue-Resident Macrophages
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
From Blood Monocytes to Adipose Tissue-Resident Macrophages
Cyrile A. Curat, Alexandra Miranville, Coralie Sengenès, Michael Diehl, Carolin Tonus, Rudi Busse, Anne Bouloumié
Diabetes May 2004, 53 (5) 1285-1292; DOI: 10.2337/diabetes.53.5.1285

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

From Blood Monocytes to Adipose Tissue-Resident Macrophages
Cyrile A. Curat, Alexandra Miranville, Coralie Sengenès, Michael Diehl, Carolin Tonus, Rudi Busse, Anne Bouloumié
Diabetes May 2004, 53 (5) 1285-1292; DOI: 10.2337/diabetes.53.5.1285
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Pancreatic Polypeptide Is Involved in the Regulation of Body Weight in Pima Indian Male Subjects
  • Fibroblast Growth Factor 1
  • Ciliary Neurotrophic FactorAx15 Alters Energy Homeostasis, Decreases Body Weight, and Improves Metabolic Control in Diet-Induced Obese and UCP1-DTA Mice
Show more Obesity Study

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.